Subscription Agreements in the Biotechnology Industry
459 Contracts & Agreements
- ACHIEVE LIFE SCIENCES, INC. (3 contracts)
- Actinium Pharmaceuticals, Inc. (2)
- Adhera Therapeutics, Inc. (2)
- ADiTx Therapeutics, Inc. (1)
- ALBIREO PHARMA, INC. (2)
- Alliqua BioMedical, Inc. (1)
- Alpha Healthcare Acquisition Corp. (6)
- Altimmune, Inc. (1)
- AMARIN CORP PLC (2)
- AmpliPhi Biosciences Corp (1)
- Amplitude Healthcare Acquisition Corp (1)
- ANAVEX LIFE SCIENCES CORP. (19)
- Aptose Biosciences Inc. (2)
- Arbutus Biopharma Corp (1)
- ARCA biopharma, Inc. (8)
- ARROWHEAD PHARMACEUTICALS, INC. (10)
- ARYA Sciences Acquisition Corp II (2)
- ASSEMBLY BIOSCIENCES, INC. (1)
- ATOSSA GENETICS INC (1)
- BCTG Acquisition Corp. (2)
- Big Cypress Acquisition Corp. (2)
- bioAffinity Technologies, Inc. (1)
- Biohaven Pharmaceutical Holding Co Ltd. (3)
- BIOTIME INC (2)
- BIOXYTRAN, INC (4)
- Bison Capital Acquisition Corp. (5)
- Blue Water Vaccines Inc. (1)
- Bone Biologics Corp (2)
- BRAINSTORM CELL THERAPEUTICS INC. (2)
- CALADRIUS BIOSCIENCES, INC. (5)
- CAPRICOR THERAPEUTICS, INC. (4)
- CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (1)
- Cell Source, Inc. (2)
- Celldex Therapeutics, Inc. (1)
- Cellular Biomedicine Group, Inc. (3)
- Celsion CORP (1)
- Chanticleer Holdings, Inc. (2)
- Chardan Healthcare Acquisition 2 Corp. (2)
- Chardan Healthcare Acquisition Corp. (1)
- Chelsea Worldwide Inc. (1)
- Cidara Therapeutics, Inc. (1)
- CM Life Sciences III Inc. (2)
- CohBar, Inc. (2)
- Consonance-HFW Acquisition Corp. (1)
- Constellation Alpha Capital Corp. (3)
- Corbus Pharmaceuticals Holdings, Inc. (3)
- CRISPR Therapeutics AG (1)
- CTI BIOPHARMA CORP (1)
- Cue Biopharma, Inc. (1)
- Curative Biotechnology Inc (4)
- CURIS INC (1)
- Cyclacel Pharmaceuticals, Inc. (3)
- CytoDyn Inc. (31)
- Cytokinetics, Incorporated (1)
- CYTORI THERAPEUTICS, INC. (3)
- DelMar Pharmaceuticals, Inc. (5)
- Diffusion Pharmaceuticals Inc. (4)
- Dynamics Special Purpose Corp. (2)
- Edge Therapeutics, Inc. (1)
- Eiger BioPharmaceuticals, Inc. (1)
- Enochian Biosciences Inc (8)
- Environmental Impact Acquisition Corp (4)
- ENZON PHARMACEUTICALS, INC. (2)
- EVOLUTIONARY GENOMICS, INC. (1)
- EXICURE, INC. (7)
- FENNEC PHARMACEUTICALS INC. (2)
- FLUOROPHARMA MEDICAL, INC. (3)
- Frequency Therapeutics, Inc. (1)
- FS Development Corp. II (1)
- GALECTIN THERAPEUTICS INC (5)
- GENOCEA BIOSCIENCES, INC. (1)
- Genprex, Inc. (2)
- GeoVax Labs, Inc. (5)
- GOLDENWELL BIOTECH, INC. (1)
- Graphite Bio, Inc. (1)
- GTX INC (2)
- GX Acquisition Corp. (2)
- Health Sciences Acquisitions Corp (1)
- HEAT BIOLOGICS, INC. (1)
- HedgePath Pharmaceuticals, Inc. (3)
- HEMISPHERX BIOPHARMA INC (1)
- Homology Medicines, Inc. (1)
- IDERA PHARMACEUTICALS, INC. (1)
- Immunome Inc. (1)
- IMMUNOMEDICS INC (1)
- Inhibikase Therapeutics, Inc. (4)
- Inmune Bio, Inc. (2)
- Innovation Pharmaceuticals Inc. (2)
- INOVIO PHARMACEUTICALS, INC. (2)
- INSMED Inc (2)
- Inspyr Therapeutics, Inc. (1)
- International Stem Cell CORP (1)
- IOVANCE BIOTHERAPEUTICS, INC. (4)
- Kadmon Holdings, Inc. (2)
- KalVista Pharmaceuticals, Inc. (2)
- KBL MERGER CORP. IV (6)
- KIWA BIO-TECH PRODUCTS GROUP CORP (1)
- LEAP THERAPEUTICS, INC. (1)
- Leisure Acquisition Corp. (2)
- LEXICON PHARMACEUTICALS, INC. (1)
- LifeSci Acquisition Corp. (4)
- Locust Walk Acquisition Corp. (2)
- LONGEVERON LLC (1)
- MADRIGAL PHARMACEUTICALS, INC. (3)
- MARIZYME INC (1)
- Marker Therapeutics, Inc. (2)
- MATEON THERAPEUTICS INC (7)
- Matinas BioPharma Holdings, Inc. (2)
- Medovex Corp. (1)
- MEI Pharma, Inc. (8)
- Millendo Therapeutics, Inc. (1)
- MiMedx Group, Inc. (2)
- MIRAGEN THERAPEUTICS, INC. (3)
- Mirum Pharmaceuticals, Inc. (2)
- Moleculin Biotech, Inc. (2)
- Momenta Pharmaceuticals, Inc. (1)
- NANOVIRICIDES, INC. (7)
- NAVIDEA BIOPHARMACEUTICALS, INC. (2)
- NORTHWEST BIOTHERAPEUTICS INC (2)
- NOVAVAX INC (3)
- NTN BUZZTIME INC (1)
- Nuo Therapeutics, Inc. (5)
- Ohr Pharmaceutical Inc (3)
- Olivia Ventures, Inc. (1)
- OncBioMune Pharmaceuticals, Inc (11)
- OncoCyte Corp (4)
- ONCOSEC MEDICAL Inc (1)
- Organicell Regenerative Medicine, Inc. (2)
- ORGANOVO HOLDINGS, INC. (1)
- Orgenesis Inc. (18)
- Pfenex Inc. (1)
- PIERIS PHARMACEUTICALS, INC. (2)
- PLURISTEM THERAPEUTICS INC (2)
- POLARITYTE, INC. (5)
- PREDICTIVE TECHNOLOGY GROUP, INC. (2)
- Propanc Biopharma, Inc. (1)
- PROTEON THERAPEUTICS INC (3)
- PROTEOSTASIS THERAPEUTICS, INC. (1)
- PUMA BIOTECHNOLOGY, INC. (1)
- Qrons Inc. (3)
- Regeneron Pharmaceuticals (1)
- REGENERX BIOPHARMACEUTICALS INC (1)
- RenovaCare, Inc. (5)
- RenovoRx, Inc. (2)
- REXAHN PHARMACEUTICALS, INC. (1)
- Rezolute, Inc. (3)
- ROCKET PHARMACEUTICALS, INC. (1)
- SANGAMO THERAPEUTICS, INC (1)
- SELLAS Life Sciences Group, Inc. (4)
- Social Capital Suvretta Holdings Corp. III (1)
- SPHERIX INC (4)
- Spinning Eagle Acquisition Corp. (2)
- Stellar Biotechnologies, Inc. (3)
- Summit Therapeutics Inc. (2)
- SYNLOGIC, INC. (3)
- Synthetic Biologics, Inc. (1)
- TENAX THERAPEUTICS, INC. (2)
- TG THERAPEUTICS, INC. (2)
- Therapeutics Acquisition Corp. (1)
- Tonix Pharmaceuticals Holding Corp. (3)
- U.S. Stem Cell, Inc. (3)
- USA EQUITIES CORP. (1)
- VBI Vaccines Inc (1)
- VistaGen Therapeutics, Inc. (5)
- WINDTREE THERAPEUTICS INC (1)
- XBiotech Inc. (1)
- Xenetic Biosciences, Inc. (2)
- XOMA Corp (1)
- ZAFGEN, INC. (1)
- ZIOPHARM ONCOLOGY INC (1)
- Form of Subscription Agreement (RenovoRx, Inc., Filed With SEC on April 15, 2024)
- Subscription Agreement, dated April 5, 2024 (PROTEON THERAPEUTICS INC, Filed With SEC on April 5, 2024)
- Form of Oruka Subscription Agreement (ARCA biopharma, Inc., Filed With SEC on April 3, 2024)
- Subscription Agreement, dated November 16, 2023, by and among Q32 Bio Operations Inc. (formerly Q32 Bio Inc.) and certain parties thereto (Homology Medicines, Inc., Filed With SEC on March 27, 2024)
- Subscription Agreement (Aptose Biosciences Inc., Filed With SEC on January 30, 2024)
- Subscription Agreement (RenovoRx, Inc., Filed With SEC on January 29, 2024)
- Form of Subscription Agreement, dated December 15, 2023, by and among Onconetix, Proteomedix, and the Investor (Blue Water Vaccines Inc., Filed With SEC on December 21, 2023)
- Subscription Agreement, dated as of November 14, 2023 (Graphite Bio, Inc., Filed With SEC on November 15, 2023)
- Subscription Agreement, dated July 10, 2023 (Diffusion Pharmaceuticals Inc., Filed With SEC on November 13, 2023)
- Subscription Agreement, dated July 14, 2023, by and among Korro Bio Ops, Inc. and certain parties thereto (Frequency Therapeutics, Inc., Filed With SEC on November 6, 2023)
- Form of Subscription Agreement (Enochian Biosciences Inc, Filed With SEC on October 10, 2023)
- Subscription Agreement, dated September 18, 2023, by and between The Joyce Living Trust, dated March 19, 2013, and bioAffinity Technologies, Inc (bioAffinity Technologies, Inc., Filed With SEC on September 20, 2023)
- Subscription Agreement (Aptose Biosciences Inc., Filed With SEC on September 12, 2023)
- Convertible Bond Subscription Agreement, dated May 16, 2023, among Cyworld Z Co., Ltd. and Exicure, Inc (EXICURE, INC., Filed With SEC on August 11, 2023)
- Convertible Bond Subscription Agreement, dated May 3, 2023, among Cyworld Z Co., Ltd. and Exicure, Inc (EXICURE, INC., Filed With SEC on August 11, 2023)
- Securities Subscription Agreement, dated as of August 8, 2023, between Novavax, Inc. and SK bioscience Co., Ltd (NOVAVAX INC, Filed With SEC on August 8, 2023)
- Form of Subscription Agreement (Mirum Pharmaceuticals, Inc., Filed With SEC on August 7, 2023)
- Form of Subscription Agreement (Enochian Biosciences Inc, Filed With SEC on August 7, 2023)
- Form of Transferable Subscription Rights Certificate (LONGEVERON LLC, Filed With SEC on July 28, 2023)
- Form of Subscription Agreement (Mirum Pharmaceuticals, Inc., Filed With SEC on July 17, 2023)
- Form of Subscription Agreement (MATEON THERAPEUTICS INC, Filed With SEC on July 13, 2023)
- Form of Subscription Agreement, dated June 29, 2023 (Immunome Inc., Filed With SEC on June 29, 2023)
- Form of Subscription Agreement (Enochian Biosciences Inc, Filed With SEC on June 28, 2023)
- Convertible Bond Subscription Agreement, dated May 16, 2023, among Cyworld Z Co., Ltd. and Exicure, Inc (EXICURE, INC., Filed With SEC on May 18, 2023)
- Form of Subscription Agreement (BIOXYTRAN, INC, Filed With SEC on May 12, 2023)
- Convertible Bond Subscription Agreement, dated May 3, 2023, among Cyworld Z Co., Ltd. and Exicure, Inc (EXICURE, INC., Filed With SEC on May 9, 2023)
- Form of Subscription Agreement (Enochian Biosciences Inc, Filed With SEC on April 3, 2023)
- Subscription Agreement, dated as of December 23, 2022, by and among KalVista Pharmaceuticals, Inc. and the purchasers identified on the signature pages thereto (KalVista Pharmaceuticals, Inc., Filed With SEC on December 27, 2022)
- Form of Subscription Agreement (ACHIEVE LIFE SCIENCES, INC., Filed With SEC on November 18, 2022)
- Form of Subscription Agreement for Investor Offerings on May 21, 2021 (Curative Biotechnology Inc, Filed With SEC on November 7, 2022)
- Form of Subscription Agreement for Investor Offerings in August 2021 (Curative Biotechnology Inc, Filed With SEC on November 7, 2022)
- Form of U.S. Subscription Agreement (Stellar Biotechnologies, Inc., Filed With SEC on November 3, 2022)
- Form of Non-U.S. Subscription Agreement (Stellar Biotechnologies, Inc., Filed With SEC on November 3, 2022)
- Form of Subscription Agreement (BIOXYTRAN, INC, Filed With SEC on August 17, 2022)
- Form of Securities Subscription Agreement dated as of August 11, 2022, between Greenlight Biosciences Holdings, PBC and each purchaser named in the signature pages thereto (Environmental Impact Acquisition Corp, Filed With SEC on August 15, 2022)
- Form of Subscription Agreement, dated April 26, 2022, between Xenetic Biosciences, Inc. and CLS Therapeutics LTD (Xenetic Biosciences, Inc., Filed With SEC on August 11, 2022)
- Form of Subscription Rights Certificate (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on August 2, 2022)
- Form of Subscription Rights Certificate (NAVIDEA BIOPHARMACEUTICALS, INC., Filed With SEC on July 20, 2022)
- Form of Subscription Rights Certificate (Summit Therapeutics Inc., Filed With SEC on July 18, 2022)
- Form of Subscription Agreement for Investor Offerings on May 21, 2021 (Curative Biotechnology Inc, Filed With SEC on April 15, 2022)
